One of the Major Drivers of the Minimally Invasive Thoracic Surgery Market Is the The Rising Incidence Of Lung Diseases Is Fueling The Growth Of The Market Due To The Increasing Need More Effective Surgical Treatments

Global Minimally Invasive Thoracic Surgery Market Global Report 2026 Market

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Will Be The Estimated Market Valuation Of The Minimally Invasive Thoracic Surgery Market By The End Of 2030?

The minimally invasive thoracic surgery market has witnessed significant growth in recent years. It is projected to expand from $4.38 billion in 2025 to $4.74 billion in 2026, achieving an 8.2% compound annual growth rate (CAGR). The expansion observed in the past can be ascribed to several factors, including a higher incidence of thoracic disorders, the proliferation of specialized surgical centers, advancements in minimally invasive surgical instruments, an increase in surgeon training for thoracoscopic techniques, and a rising patient preference for minimally invasive procedures.

The market for minimally invasive thoracic surgery is projected to experience robust expansion over the coming years. This market is anticipated to reach a valuation of $6.46 billion by 2030, progressing at a compound annual growth rate (CAGR) of 8.1%. This forecasted growth is linked to factors such as the increasing embrace of advanced robotic platforms, the growing incorporation of AI-powered surgical planning, the enlargement of outpatient thoracic surgery initiatives, the rising need for high-definition imaging technologies, and a heightened emphasis on surgical care focused on patient outcomes. Key developments during this period are expected to involve the wider uptake of robotic-assisted thoracic procedures, increased utilization of sophisticated visualization systems, a growing inclination towards video-assisted methods, the broadening application of precision energy devices, and a stronger emphasis on minimizing recovery periods after surgery.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27348&type=smp

What Primary Drivers Are Shaping The Development Of The Minimally Invasive Thoracic Surgery Market?

The increasing occurrence of lung conditions is anticipated to fuel the expansion of the minimally invasive thoracic surgery market moving ahead. These conditions encompass medical ailments like asthma, COPD, pneumonia, and lung cancer, which hinder normal lung operation and respiration. A primary contributor to the rise in lung disease is tobacco smoking, as the detrimental substances in tobacco progressively harm lung cell DNA, elevating the risk of unchecked cellular proliferation and tumor development. This minimally invasive approach aids patients with lung conditions by targeting, excising, or eliminating tumors via small cuts or probes guided by imaging, thereby shortening recuperation periods, lessening harm to healthy lung tissue, decreasing complication risks, and enabling patients to return to their routine activities more quickly. For example, reports from June 2025 by the Centers for Disease Control and Prevention, a US-based government administration, indicated that in 2022, the United States registered 218,893 new cases of lung cancer, and by 2023, lung cancer resulted in 131,584 fatalities within the nation. Consequently, the growing frequency of lung illnesses is propelling the expansion of the minimally invasive thoracic surgery market.

Which Segment Classifications Shape The Minimally Invasive Thoracic Surgery Market?

The minimally invasive thoracic surgery market covered in this report is segmented –

1) By Surgical Resection Type: Lobectomy, Wedge Resection, Pneumonectomy, Other Types

2) By Product: Energy Devices, Instruments, Staplers And Disposables, Visualization Systems

3) By Procedure Type: Video-Assisted Thoracoscopic Surgery (VATS), Robotic-Assisted Thoracic Surgery, Endoscopic Thoracic Surgery, Other Procedure Types

4) By Application: Lung Cancer Surgery, Esophageal Surgery, Mediastinal Surgery, Other Applications

5) By End-User: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Other End-Users

Subsegments:

1) By Lobectomy: Bilobectomy, Sleeve Lobectomy, Thoracoscopic Lobectomy (VATS Lobectomy), Robotic-Assisted Lobectomy

2) By Wedge Resection: Video-Assisted Thoracoscopic Surgery (VATS) Wedge Resection, Robotic-Assisted Wedge Resection, Open Wedge Resection

3) By Pneumonectomy: Standard Pneumonectomy, Extended Pneumonectomy, Sleeve Pneumonectomy, Thoracoscopic

4) By Other Types: Segmentectomy, Sleeve Resection, Decortication, Bullectomy, Thoracoscopic Resection For Metastasectomy

Which Trends Are Influencing The Minimally Invasive Thoracic Surgery Market?

Leading companies in the minimally invasive thoracic surgery market are prioritizing the development of innovative technologies, such as robotic-assisted surgery platforms, to enhance surgical accuracy and improve overall clinical results. A robotic-assisted surgery platform functions as a surgical system where surgeons manipulate robotic arms to conduct minimally invasive procedures with significant precision, thereby boosting accuracy, dexterity, and visualization when compared to traditional operations. For instance, in June 2024, Monmouth Medical Centre (MMC), a US-based medical institution, unveiled the Ion Robotic platform, the Aliya PEF system, and intraoperative AI-driven CT imaging. This suite of technologies delivers advantages including heightened surgical precision, superior patient outcomes, and real-time imaging to aid in better decision-making. Collectively, these advancements facilitate minimally invasive and accurate lung cancer diagnosis and treatment, resulting in quicker recovery times and excellent patient results. They offer capabilities such as real-time navigation, non-thermal tumor ablation, and reduced radiation exposure, thereby encouraging early detection and effective healthcare.

Which Companies Are Expanding Their Footprint In The Minimally Invasive Thoracic Surgery Market?

Major companies operating in the minimally invasive thoracic surgery market are Johnson And Johnson Services Inc., Medtronic Plc, Koninklijke Philips N.V., Stryker Corporation, GE Healthcare Inc., Olympus Corporation, Intuitive Surgical Operations Inc., Smith & Nephew plc, Teleflex Incorporated, Karl Storz SE & Co. KG, Cook Group Incorporated, CONMED Corporation, Applied Medical Resources Corporation, KLS Martin Group, Aesculap Inc., Medela Inc., Richard Wolf GmbH, B. Braun Melsungen AG, Ackermann Instrumente GmbH, Cmr Surgical, Genesee Biomedical Inc.

Read the full minimally invasive thoracic surgery market report here:

https://www.thebusinessresearchcompany.com/report/minimally-invasive-thoracic-surgery-global-market-report

How Does The Minimally Invasive Thoracic Surgery Market Perform Across Major Global Regions?

North America was the largest region in the minimally invasive thoracic surgery market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the minimally invasive thoracic surgery market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Minimally Invasive Thoracic Surgery Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=27348&type=smp

Browse Through More Reports Similar to the Global Minimally Invasive Thoracic Surgery Market 2026, By The Business Research Company

Rare Disease Diagnostics Global Market Report

https://www.thebusinessresearchcompany.com/report/rare-disease-diagnostics-global-market-report

Rare Diseases Treatment Global Market Report

https://www.thebusinessresearchcompany.com/report/rare-diseases-treatment-global-market-report

Rare Neurological Disease Treatment Global Market Report

https://www.thebusinessresearchcompany.com/report/rare-neurological-disease-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model